Geneva Advisors’s Eastman Chemical EMN Stock Holding History

Geneva Advisors’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$652K	Hold	7,767	–	–	0.01%	454
2017 Q1	$628K	Sell	7,767 -521	-6%	-$41K	0.01%	446
2016 Q4	$623K	Sell	8,288 -218	-3%	-$15.7K	0.01%	444
2016 Q3	$576K	Sell	8,506 -354	-4%	-$23.8K	0.01%	443
2016 Q2	$602K	Buy	8,860 +1	+0%	+$73	0.01%	402
2016 Q1	$640K	Buy	8,859 +2	+0%	+$131	0.01%	382
2015 Q4	$598K	Buy	8,857 +2	+0%	+$140	0.01%	382
2015 Q3	$573K	Buy	8,855 +5,232	+144%	+$386K	0.01%	370
2015 Q2	$296K	Buy	+3,623	New	+$279K	0.01%	527
2015 Q1	–	Sell	-3,981	Closed	-$302K	–	709
2014 Q4	$302K	Sell	3,981 -220	-5%	-$17.4K	0.01%	507
2014 Q3	$340K	Sell	4,201 -240	-5%	-$20K	0.01%	493
2014 Q2	$388K	Buy	4,441 +675	+18%	+$58.7K	0.01%	474
2014 Q1	$325K	Buy	+3,766	New	+$309K	0.01%	459

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geneva Advisors's EMN Position: Q2 2017 in Review

Geneva Advisors held its Eastman Chemical (EMN) position steady in Q2 2017 at 7,767 shares worth $652K. The position accounts for 0.01% of the portfolio, ranked #454.

Geneva Advisors first reported a position in EMN in Q1 2014 and has held it in 13 quarters since. 618 funds tracked by Wall St. Rank hold EMN as of Q2 2017.

Geneva Advisors held 7,767 shares of Eastman Chemical worth $652K as of Q2 2017.
Geneva Advisors left its Eastman Chemical share count unchanged in Q2 2017.
Eastman Chemical made up 0.01% of Geneva Advisors's portfolio in Q2 2017, its #454 holding.
Geneva Advisors first reported a position in Eastman Chemical in Q1 2014 and has held it in 13 quarters since.
618 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.